我国基本药物可及性研究的Meta分析
x

请在关注微信后,向客服人员索取文件

篇名: 我国基本药物可及性研究的Meta分析
TITLE:
摘要: 目的:系统评价我国基本药物制度实施后药物的可及性水平。方法:检索2009-2017年中国生物医学文摘数据库、中国知网、维普网和万方数据中关于我国基本药物制度实施后药物可及性水平研究的文献 ,对符合纳入标准的文献进行资料提取后 ,采用Stata MP 14.0软件对数据进行Meta分析(包括药物总体可及性、基本药物可及性、公立医院区域可及性、零售药店区域可及性和基层医疗卫生机构区域可及性)。结果:共纳入文献13篇。Meta分析结果表明 ,我国药物总体可及性合并值为43.4%[95%CI(35.8%,51.3%)],基本药物可及性合并值为43.6%[95%CI(34.8%,52.8%)];其中公立医院区域可及性合并值为42.3%[95%CI(22.9%,55.6%)],零售药店区域可及性合并值为45.3%[95%CI(36.4%,55.5%)],基层医疗卫生机构区域可及性合并值为55.0%[95%CI(46.9%,63.0%)]。结论:我国基本药物可及性基本达到预期水平,总体可获得性程度为中等水平。
ABSTRACT: OBJECTIVE: To systematically evaluate the availability level of medicine after the implementation of essential medicine system in China. METHODS: The literatures about the availability of medicine after the implementation of essential medicine system in China were retrieved from CBM, CNKI, VIP and Wanfang databases during 2009-2017. After data extraction of included literatures which met inclusion criteria, Meta-analysis was performed by using Stata MP 14.0 software (including general availability of medicine, availability of essential medicines, regional availability of public hospital, retail pharmacy and primary medical institution). RESULTS: 13 literatures were included in this study. Results of Meta-analysis showed that combined value of general availability of medicine was 43.4% [95%CI(35.8%, 51.3%)]; combined value of availability of essential medicines were 43.6% [95%CI(34.8%, 52.8%)]. The combined value of regional availability of public hospital was 42.3% [95%CI(22.9%, 55.6%)]; that of retail pharmacy was 45.3% [95%CI(36.4%, 55.5%)]; that of primary medical institution was 55.0% [95%CI(46.9%, 63.0%)]. CONCLUSIONS: The availability of essential medicines in our country reached a expected, intermediate level.
期刊: 2018年第29卷第15期
作者: 王伟,任亚男,包晗,邱鹏程,张鑫磊,祁永飞,颜真,王玉琨
AUTHORS: WANG Wei,REN Yanan,BAO Han,QIU Pengcheng,ZHANG Xinlei,QI Yongfei,YAN Zhen,WANG Yukun
关键字: 基本药物;基本药物制度;可及性;Meta分析
KEYWORDS: Essential medicines; Essential Medicine System; Availability; Meta-analysis
阅读数: 392 次
本月下载数: 11 次

* 注:未经本站明确许可,任何网站不得非法盗链资源下载连接及抄袭本站原创内容资源!在此感谢您的支持与合作!